hyaluronoglucosaminidase has been researched along with HPV Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barzon, L; Carosso, A; Cosci, I; De Toni, L; Engl, B; Foresta, C; Garolla, A | 1 |
| Chariot, A; Close, P; Delvenne, P; Göktuna, SI; Gothot, A; Hennuy, B; Hildebrand, J; Hubert, P; Jiang, Z; Klevernic, I; Ladang, A; Roncarati, P; Shostak, K; Somja, J; Zhang, X | 1 |
2 other study(ies) available for hyaluronoglucosaminidase and HPV Infection
| Article | Year |
|---|---|
Hyaluronidase-based swim-up for semen selection in patients with human papillomavirus semen infection.
Topics: Humans; Hyaluronoglucosaminidase; Male; Papillomaviridae; Papillomavirus Infections; Semen Analysis; Spermatozoa | 2021 |
NF-κB-induced KIAA1199 promotes survival through EGFR signalling.
Topics: B-Cell Lymphoma 3 Protein; Cell Survival; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; ErbB Receptors; HeLa Cells; Humans; Hyaluronoglucosaminidase; Keratinocytes; Lysosomes; MCF-7 Cells; Papillomavirus Infections; Proteins; Proto-Oncogene Proteins; Semaphorin-3A; Transcription Factor RelA; Transcription Factors; Uterine Cervical Dysplasia | 2014 |